An alarming number of newborns are reportedly bleeding to death across the United States, a tragic consequence linked to a growing trend of parents refusing the routine Vitamin K shot administered at birth. This critical vitamin injection prevents a potentially fatal bleeding disorder in infants, yet its rejection is now associated with a rise in severe and often deadly internal hemorrhages, prompting widespread concern among medical professionals.
Reports from multiple media outlets highlight a concerning public health issue: a significant increase in infant bleeding deaths directly attributed to parents opting out of the standard Vitamin K prophylaxis for their newborns. This routine injection, typically administered shortly after birth, proves crucial for preventing Vitamin K deficiency bleeding (VKDB), a severe and potentially fatal condition where infants experience uncontrollable internal hemorrhaging, often affecting the brain.
Journalistic investigations by publications such as ProPublica, USA Today, and People.com consistently underscore the deadly consequences of this parental decision. These outlets detail tragic cases where newborns, deprived of the vital vitamin, suffered severe internal bleeds that proved fatal. The alarming trend prompts widespread concern among medical professionals and public health advocates, who emphasize the shot's proven safety and efficacy in safeguarding infant health.
The rising refusal rates are reportedly fueled by various factors, including misinformation and anti-vaccine sentiment circulating online, as noted by sources like MSN and Genetic Literacy Project. One report from WION even points to political figures being blamed for creating doubt about crucial vitamins. This environment of skepticism leads some parents to reject a simple, life-saving intervention, inadvertently placing their infants at grave risk. Experts consistently affirm that the Vitamin K shot remains a cornerstone of newborn care, designed to protect vulnerable infants from a preventable and often devastating condition.
By JKN Global News Desk



![[금융진단] 미 증시, 지정학 완화·빅테크 반등에 상승](https://images.jkn.co.kr/data/images/full/98/28/982892.jpg?aspect_ratio=288:168&crop_gravity=northwest&width=288)

